Welcome to our dedicated page for IBEX SEC filings (Ticker: IBEX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
IBEX Limited SEC filings document the company's public-company reporting for its business process outsourcing and AI-powered customer experience operations. Recent 8-K filings furnish quarterly and annual financial results, operating outlook updates, press-release exhibits, and Inline XBRL cover data for a Bermuda registrant that identifies as an emerging growth company.
IBEX proxy and governance filings cover annual general meeting matters, board structure, director elections, authority to fill board vacancies, long-term incentive plan approvals, auditor appointment votes, and committee governance. Material-event filings also document board committee changes and other corporate governance disclosures tied to the company's Nasdaq-listed reporting obligations.
IBEX Limited reported a proposed sale of 10,000 common shares through RBC Capital Markets with an approximate aggregate market value of $300,013. The filing states the shares represent stock grants acquired on 04/20/2022 from the issuer and that the sale is expected on 08/22/2025 on NASDAQ. The filing shows 13,372,404 shares outstanding, and no other sales by the reporting person in the past three months are reported. The filer also affirms they are not aware of any undisclosed material adverse information and notes the legal warning about intentional misstatements.
IBEX Ltd (IBEX) Form 4 filing discloses two open-market sales by Chief Executive Officer and Director Robert Thomas Dechant on 2 and 3 July 2025. The transactions involved a total of 5,000 common shares sold at $30.00 per share, producing proceeds of roughly $150,000. Following the dispositions, Dechant’s direct ownership declined from 198,633 to 193,633 shares, a reduction of about 2.5% of his previously held stake. No derivative security activity was reported, and the filing was submitted individually on 3 July 2025.
The modest size of the sale relative to Dechant’s remaining holdings suggests routine portfolio management rather than a wholesale change in insider sentiment. Nonetheless, any CEO sale can attract investor attention, particularly when not explicitly tied to a pre-arranged 10b5-1 trading plan (the form does not indicate such a plan was in place).